^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    KAHR-102

    i
    Other names: KAHR-102, CTLA-4/FasL fusion protein, CD95L
    Associations
    News
    Trials
    Company:
    Kahr Medical
    Drug class:
    CD80 inhibitor, CD86 inhibitor, FasL stimulant
    Related drugs:
    Associations
    News
    Trials